VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
HUMAHumacyte, Inc.
$0.73$123M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksHUMAQuarterly Cash Flow

Humacyte, Inc. (HUMA) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Humacyte, Inc. (HUMA) quarterly cash flow statement — complete operating, investing & financing history

HUMA Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Cash from Operations-25.1M-26.12M-23.9M-26.41M-28.6M-26.58M-22.91M-21.29M-27.35M-19.05M-13.01M-22.6M
Operating CF Margin %-5071.52%-5594%-3174.5%-8775.08%-5532.11%-367.7%------
Operating CF Growth %12.23%1.7%-4.35%-24.06%-4.59%-39.48%-76.11%5.8%-46.7%-0.5%22.6%-36.42%
Net Income-17.62M-24.8M-17.51M-37.66M39.14M-20.94M-39.2M-56.66M-31.9M-25.11M-26M-22.71M
Depreciation & Amortization01.34M1.86M1.86M1.83M-322K1.81M1.78M1.79M3.38M1.83M2M
Stock-Based Compensation02.47M2.46M2.33M2.49M1.69M1.55M1.44M1.45M1.41M1.77M0
Deferred Taxes000000000-4.64M135K0
Other Non-Cash Items-6.18M3.18M-6.6M8.45M-62.49M-4.2M9.52M28.1M5.96M2.78M2.2M1.56M
Working Capital Changes-1.3M-8.31M-4.12M-1.4M-9.56M-2.81M3.41M4.06M-4.66M3.13M7.05M-3.45M
Change in Receivables7K637K-684K94K-308K0000000
Change in Inventory2.04M-3.56M-7.3M-2.95M-8.02M0000000
Change in Payables-362K-4.16M2.99M1.49M653K-2.44M1.11M2.31M-2.95M3.52M526K467K
Cash from Investing-175K-39K-49K-568K-228K-63K-934K-184K-391K-150K-493K1.62M
Capital Expenditures-175K-39K-49K-568K-228K-63K-934K-184K-391K-150K-493K-485K
CapEx % of Revenue35.35%8.35%6.51%188.7%44.1%0.87%------
Acquisitions000000000000
Investments------------
Other Investing000000000000
Cash from Financing23.32M57.17M-44.59M2.17M46.74M51.01M849K-467K62.8M-335K-764K6.01M
Debt Issued (Net)038.54M-743K-727K-687K1.67M-659K-404K-603K-588K-577K-31.98M
Equity Issued (Net)23.32M56.59M9.8M3.23M47M1.52M1.01M787K43.4M253K99K95K
Dividends Paid000000000000
Share Repurchases000000000000
Other Financing0-37.95M-53.65M-340K426K47.82M495K-850K20M0-286K37.9M
Net Change in Cash-1.96M31.01M-68.54M-24.96M17.91M24.37M-22.99M-21.94M34.91M-19.54M-14.26M-14.97M
Free Cash Flow-25.28M-26.16M-23.95M-26.98M-28.83M-26.64M-23.84M-21.48M-27.74M-19.2M-13.5M-23.09M
FCF Margin %-5106.87%-5602.36%-3181.01%-8963.79%-5576.21%-368.57%------
FCF Growth %12.31%1.79%-0.47%-25.64%-3.93%-38.72%-76.6%6.99%-40.14%2.22%20.66%-38.23%
FCF per Share-0.13-0.17-0.15-0.17-0.22-0.22-0.20-0.18-0.26-0.19-0.13-0.22
FCF Conversion (FCF/Net Income)1.42x1.05x1.37x0.70x-0.73x1.27x0.58x0.38x0.86x0.76x0.50x1.00x
Interest Paid000000000000
Taxes Paid000000000000